Genmab | Vermögenswerte



Assets Veränderung Datum
Agios Pharmaceuticals USD 1.66B 128.6M 2024-12
Almirall EUR 2.32B 14.19M 2024-06
Amarin USD 750.62M 49.24M 2024-09
Amgen USD 91.84B 956M 2024-12
AstraZeneca USD 106.25B 2.22B 2025-03
Bayer EUR 110.85B 3.9B 2024-12
BioMarin Pharmaceutical USD 6.99B 137.74M 2024-12
Demant DKK 32.45B 60M 2024-12
Exelixis USD 2.95B 12.59M 2025-01
Fresenius Medical Care EUR 33.57B 1.06B 2024-12
Galapagos EUR 4.02B 113.77M 2025-03
Genmab DKK 45.81B 6.15B 2024-12
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
GN Store Nord DKK 29.94B 8.26B 2025-03
GRIFOLS EUR 21.41B 1.12B 2024-12
Hikma Pharmaceutical USD 4.85B 167M 2024-06
Insmed USD 2.03B 27.74M 2024-12
Lonza CHF 19.73B 1.85B 2024-12
Merck EUR 51.57B 1.42B 2024-12
Novartis USD 102.25B 1.28B 2024-12
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 131.89B 906M 2025-03
UCB EUR 17.35B 1.72B 2024-12



Genmab Vermögenswerte - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.